The present disclosure relates to improved methods and apparatuses for traversing a tortuous vasculature. Specifically, the present disclosure relates to providing support to procedural catheters during lower extremity intervention procedures to traverse the procedural site through the tortuous access vessels.
Technology associated with interventional procedures is ever developing, particularly in the areas of stenting and balloon angioplasty of Interventional procedures are typically challenging, as accessing various regions of the artery can be dependent on the anatomical disposition of the access location. Specifically, accessing regions of a tortuous peripheral arteries and performing interventional procedures in a hostile anatomy can be very difficult. Furthermore, the subsequent removal of blockages and placement of a stent delivery system into aorto femoral arteries becomes more difficult, or in some instances impossible. The interventional procedure may also be difficult for the popliteal and tibial arteries. The stenting procedure is meant to re-establish a more normalized blood flow through these tortuous arteries by opening up regions constricted by plaque or embolic deposits, which inhibit blood flow.
Although the stent delivery systems are designed to accommodate very acute bends, they are reliant upon guide catheters, guide wires and/or embolic protection devices during deployment. When long delivery systems in tortuous arteries the pushability of catheters and guide wires become critical. As a result, the rigid or stiff catheters and guide wires are needed to manipulate the tortuous entry. With these type of rigid devices, injuries to the tortuous arteries and access vessels often occur during the insertion, manipulation and stabilization of the stent delivery mechanism. Injuries to the tortuous arteries and access vessels often occur during removal of the guide wires, secondary equipment and wires as well. Specifically, the injuries can be caused by puncturing or cutting into the arterial walls resulting in dissections and trauma to the vessels involved. These traumas can be dangerous to the patient as they can ultimately affect blood flow by leakage at the dissections. In some instances, the traumas can create accumulation of thrombus, which is an organization of white blood cells. Dissections and the accumulation of thrombus can require additional procedures to repair and heal the damaged artery walls.
In view of the foregoing, there exists a need to provide a simplified procedure that reduces the injuries caused to the arterial walls during lower extremity interventions. Furthermore, there exists a need to for a usable sheath and catheter stabilization system than enable the use of softer catheters and less stiff guide wires for the treatment of lower extremities.
In order to describe the manner in which the above-recited disclosure and its advantages and features can be obtained, a more particular description of the principles described above will be rendered by reference to specific examples illustrated in the appended drawings. These drawings depict only example aspects of the disclosure, and are therefore not to be considered as limiting of its scope. These principles are described and explained with additional specificity and detail through the use of the following drawings.
The present invention is described with reference to the attached figures, where like reference numerals are used throughout the figures to designate similar or equivalent elements. The figures are not drawn to scale, and they are provided merely to illustrate the instant invention. Several aspects of the invention are described below with reference to example applications for illustration. It should be understood that numerous specific details, relationships, and methods are set forth to provide a full understanding of the invention. One having ordinary skill in the relevant art, however, will readily recognize that the invention can be practiced without one or more of the specific details, or with other methods. In other instances, well-known structures or operations are not shown in detail to avoid obscuring the invention. The present invention is not limited by the illustrated ordering of acts or events, as some acts may occur in different orders and/or concurrently with other acts or events. Furthermore, not all illustrated acts or events are required to implement a methodology in accordance with the present disclosure.
The present disclosure provides a system and method for providing access to tortuous arteries to perform lower extremity interventions. The present disclosure is directed towards employing a flat fixed wire bifurcated catheter. The flat fixed wire bifurcated catheter includes a flat wire fixed along the length of the bifurcated catheter from its proximal end to the bifurcation. The flat wire can emerge from a side hole at the bifurcation end of the bifurcated catheter to extend for an additional length beyond the bifurcation. The distal end of the bifurcated catheter can be configured to have a dual lumen (e.g., a large procedural lumen and a small stabilization lumen) from which the flat wire emerges. Alternatively, the distal end of the bifurcated catheter can be configured to have a procedural lumen and a side hole for the stabilization wire.
A small sheath can be provided to enable percutaneous access for the distal end of the support wire. A push and pull force can be applied to the bifurcated catheter to enable the bifurcated catheter to traverse the tortuous vessels to the site of the bifemoral bypass location. This process allows the bifurcated catheter to be positioned in either the common femoral artery or the proximal superficial femoral artery. Furthermore, the stabilization wire can be locked at the accesses to apply tension and stabilization to the procedural lumen.
It should be understood by one of ordinary skill in the art, that the disclosed apparatus can be implemented in any type of lower extremity peripheral arterial intervention. In addition, the disclosed apparatus can be implemented within the internal iliac artery vascular distribution (e.g., uterine artery embolization, prostate artery embolization, proximal internal iliac artery embolization prior to endovascular common iliac artery aneurysm repair, etc.). The disclosed system and method can reduce injury to the vessels within the arteries, reduce trauma caused during the intervention procedure, and improve the procedural success rate. The disclosed system and method can also improve navigation speed through difficult anatomy and enhance stability.
The right common iliac 103 can be split into a right external iliac 105 and a right internal iliac 112b. The right external iliac 105 can be connected to a right common femoral 107, which splits into a right deep femoral 113b and a right superficial femoral 109.
When performing interventions within the tortuous vessel artery 100, it is common to encounter difficulties associated with pushability and torque. As the catheters and wires are guided over a highly angulated aortic bifurcation 115 or through the extremely tortuous common iliac arteries 103 and 104, it can be extremely difficult to apply torque. Furthermore, these arteries can contain calcific plaques or other obstructions which can add anatomic and technical challenges with traversing the tortuous vessel artery 100.
The bifurcated catheter can have a proximal end (not shown) and a distal end. The distal end can include a side hole 305 for a stabilization wire. The fixed flat wire 302 can be extended from the proximal end (not shown) of the bifurcated catheter 300 to the side hole 305. The bifurcated catheter 300 can also include a bifurcated sheath 301 that spans almost the entire length of the bifurcated catheter 300. In some embodiments, the bifurcation sheath 301 is approximately 2 centimeters from the distal end of the bifurcated catheter 300. For example, in some embodiments the bifurcated catheter 300 can include a radio opaque band 304 at its distal end that limits the length of the bifurcated sheath 301.
The radio opaque band 304 can be implemented to track the distal end of the bifurcated catheter 300 as it is advanced through the arteries of
Furthermore, the stabilization wire 306 can be a flat wire or a round wire. For example, the stabilization wire 306 can be made up of a solid or hollow member with a cross-section that is round, flat, rectangular, or a combination thereof. The stabilization wire 306 can be fabricated using commonly known materials in the art including, for example, stainless steel, nickel titanium, composites, metal reinforced polymer, polymer, a combination thereof, or the like.
At step 901, a small 4 Fr lumen snare access sheath is inserted into the left common femoral artery to provide an ipsilateral retrograde access. A snare catheter is inserted through the snare access sheath with a snare wire. The snare catheter can be 4 Fr or smaller. The snare wire can have a 20-30 mm snare at its distal end. In some embodiments, the snare wire can have a snare less than 20 mm at its distal end. The snare wire can be guided to the aortic bifurcation.
At step 902, a main access sheath can be used to establish a contralateral retrograde access at the right common femoral artery location. The main access sheath can be a 7 Fr. Lumen. A large sheath catheter can be advanced up the right femoral artery and the iliac arteries towards the aortic bifurcation. The large sheath catheter can be guided using radiographic imaging. The large sheath catheter can be Fr.7.
At step 903, a modified bifurcated catheter can be inserted into the main sheath and guided to the aortic bifurcation. The modified bifurcated catheter can have a fixed flat wire secured to the bifurcated catheter, from its proximal end to the bifurcation. An extension of the flat wire can emerge through a side exit hole at the bifurcation. The extension can be the stabilization wire. The side exit hole at the bifurcation can be between 2-4 cm prior to the distal end of the bifurcated catheter. In some embodiments, the stabilization wire can have a length of 6 to 13 cm beyond the side exit hole. In alternative embodiments, the stabilization wire can be extended beyond 13 cm from the side exit hole.
At step 904 the stabilization wire, extending from the side exit hole, can be captured by the snare of the snare wire. The snare wire can capture the stabilization wire at the aortic bifurcation. The snare can be tightened to secure the stabilization wire and apply a pull pressure on it.
At step 905 a reverse curve catheter can be inserted through the main lumen of the bifurcated catheter to access the left common iliac artery. The reverse curve catheter can assist in transitioning the bifurcated catheter from the contralateral right common iliac artery to the ipsilateral left common iliac artery over the aortic bifurcation.
At step 906, an external pull force can be applied on the snare wire with the stabilization wire snared. The pull force can be accomplished by implementing a small stabilization sheath. By pulling the small stabilization sheet, the attached fixed flat wire and the main lumen are also pulled over the reverse curve catheter into the contralateral common left iliac artery.
At step 907 a push force is applied on the bifurcated catheter at its proximal end to assist advance the bifurcated catheter past sharp corners and reduce tension on the catheter as it is pulled by the stabilization wire. The combination of the push and pull force enable the bifurcated catheter to easily overcome obstructions as it traverses tortuous curves of the vessels. The combination of push and pull forces also help to reduce the tension on the bifurcated catheter and increase access while reducing the trauma to the vessels.
At step 908 the bifurcated sheath is simultaneously pulled and pushed down the ipsilateral left side vasculature, until the side exit hole of the stabilization wire is at the ipsilateral snare access sheath location. The stabilization wire is externalized by pulling the snare wire out of the access sheath through the ipsilateral access.
At step 909 the externalized stabilization wire is anchored by locking it in place at the ipsilateral access by a wire lock. The modified bifurcated catheter is anchored at the distal end of the bifurcation.
At step 910, a tension is applied to the fixed Flat wire at the proximal end of the bifurcated catheter. The tension is applied at the contralateral access with the stabilization wire. The stabilization wire can be locked in place at the distal end. An end-to-end application of tension can be applied to provide stability to the bifurcated catheter. This stability increases pushability of any procedural catheters within its main procedural lumen.
At step 911 any optional reverse curve catheter can be used. Furthermore, any dialator used to reduce trauma to vessels can be removed from the bifurcated catheter.
At step 912 the bifurcated catheter is configured to accept the procedural catheters and instruments for procedure, through its main lumen. Stabilization and tension can be provided by the locked stabilization wire at the distal end of the bifurcation and the fixed flat wire. The bifurcated catheter is configured for interventional procedures (stents, atherectomy, etc.) within the left peripheral vasculature. The process 900 is terminated after step 912.
The examples provided herein are directed towards specific examples. One of ordinary skill in the art would understand the provided examples are not intended to be exhaustive. There exists other exemplary access and stabilization of a procedural catheter or sheath. As is well understood, the preferred method will vary based on the location of the procedure and the physical condition of the patient.
As is well understood by those familiar with the art, the invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. Likewise, the naming and division of the members, features, attributes, and other aspects are not mandatory or significant, and the mechanisms that implement the invention or its features may have different structural construct, names, and divisions. Accordingly, the disclosure of the invention is intended to be illustrative, but not limiting, of the scope of the invention.
The embodiments disclosed herein can be implemented as hardware, firmware, software, or any combination thereof. Moreover, the software is preferably implemented as an application program tangibly embodied on a program storage unit or computer readable medium. The application program may be uploaded to, and executed by, a machine comprising any suitable architecture.
This application is a continuation of U.S. patent application Ser. No. 16/183,066, entitled “A MODIFIED FIXED FLAT WIRE BIFURCATED CATHETER AND ITS APPLICATION IN LOWER EXTREMITY INTERVENTIONS,” and filed on Nov. 7, 2018, which claims priority under 35 U.S.C. § 119 to U.S. Provisional Application No. 62/631,904, entitled “MODIFIED FIXED FLAT WIRE BIFURCATED CATHETER AND ITS APPLICATION IN AORTO BIFEMORAL BYPASS,” and filed on Feb. 18, 2018, the contents of each of which are hereby incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3896815 | Fettel | Jul 1975 | A |
4243040 | Beecher | Jan 1981 | A |
4790331 | Okada et al. | Dec 1988 | A |
5098707 | Baldwin et al. | Mar 1992 | A |
5293772 | Carr, Jr. | Mar 1994 | A |
5344426 | Lau et al. | Sep 1994 | A |
5419777 | Hofling | May 1995 | A |
5433705 | Giebel et al. | Jul 1995 | A |
5571135 | Fraser et al. | Nov 1996 | A |
5651366 | Liang et al. | Jul 1997 | A |
5653743 | Martin | Aug 1997 | A |
5662703 | Yurek et al. | Sep 1997 | A |
5669924 | Shaknovich | Sep 1997 | A |
5690644 | Yurek et al. | Nov 1997 | A |
5718702 | Edwards | Feb 1998 | A |
5720735 | Dorros | Feb 1998 | A |
5766192 | Zacca | Jun 1998 | A |
5807330 | Teitelbaum | Sep 1998 | A |
5813976 | Filipi et al. | Sep 1998 | A |
5824055 | Spiridigliozzi | Oct 1998 | A |
5957901 | Mottola et al. | Sep 1999 | A |
5997563 | Kretzers | Dec 1999 | A |
6027462 | Greene et al. | Feb 2000 | A |
6059813 | Vrba et al. | May 2000 | A |
6070589 | Keith et al. | Jun 2000 | A |
6152141 | Stevens et al. | Nov 2000 | A |
6224587 | Gibson | May 2001 | B1 |
6238410 | Vrba et al. | May 2001 | B1 |
6245017 | Hashimoto | Jun 2001 | B1 |
6245573 | Spillert | Jun 2001 | B1 |
6428567 | Wilson et al. | Aug 2002 | B2 |
6450964 | Webler | Sep 2002 | B1 |
6464665 | Heuser | Oct 2002 | B1 |
6494875 | Mauch | Dec 2002 | B1 |
6544278 | Vrba et al. | Apr 2003 | B1 |
6652556 | Vantassel | Nov 2003 | B1 |
6663613 | Lewis et al. | Dec 2003 | B1 |
6764505 | Hossainy et al. | Jul 2004 | B1 |
6780174 | Mauch | Aug 2004 | B2 |
6808520 | Fouirkas et al. | Oct 2004 | B1 |
6837881 | Barbut | Jan 2005 | B1 |
6929633 | Evans et al. | Aug 2005 | B2 |
6932829 | Majercak | Aug 2005 | B2 |
6942682 | Vrba et al. | Sep 2005 | B2 |
7235083 | Perez | Jun 2007 | B1 |
7393358 | Malewicz | Jul 2008 | B2 |
7651520 | Fischell et al. | Jan 2010 | B2 |
7674493 | Hossainy et al. | Mar 2010 | B2 |
7740791 | Kleine et al. | Jun 2010 | B2 |
7758624 | Dorn et al. | Jul 2010 | B2 |
7763010 | Evans et al. | Jul 2010 | B2 |
7766961 | Patel et al. | Aug 2010 | B2 |
7828832 | Belluche et al. | Nov 2010 | B2 |
7842026 | Cahill et al. | Nov 2010 | B2 |
7955370 | Gunderson | Jun 2011 | B2 |
8092509 | Dorn et al. | Jan 2012 | B2 |
8119184 | Hossainy et al. | Feb 2012 | B2 |
8202309 | Styrc | Jun 2012 | B2 |
8241241 | Evans et al. | Aug 2012 | B2 |
8343181 | Duffy et al. | Jan 2013 | B2 |
8419767 | Al-Qbandi et al. | Apr 2013 | B2 |
8535290 | Evans et al. | Sep 2013 | B2 |
8721714 | Kelley | May 2014 | B2 |
8727988 | Flaherty et al. | May 2014 | B2 |
8728144 | Fearnot | May 2014 | B2 |
8740971 | Iannelli | Jun 2014 | B2 |
8986241 | Evans et al. | Mar 2015 | B2 |
8998894 | Mauch et al. | Apr 2015 | B2 |
9301830 | Heuser et al. | Apr 2016 | B2 |
9314499 | Wang et al. | Apr 2016 | B2 |
9414824 | Fortson | Aug 2016 | B2 |
9636244 | Syed | May 2017 | B2 |
9855705 | Wang et al. | Jan 2018 | B2 |
9980838 | Syed | May 2018 | B2 |
10492936 | Syed | Dec 2019 | B2 |
10779976 | Syed | Sep 2020 | B2 |
10857014 | Syed | Dec 2020 | B2 |
10888445 | Syed | Jan 2021 | B2 |
11007075 | Bagoaisan | May 2021 | B2 |
11020256 | Syed | Jun 2021 | B2 |
20010003985 | Lafontaine et al. | Jun 2001 | A1 |
20010049534 | Lachat | Dec 2001 | A1 |
20020077691 | Nachtigall | Jun 2002 | A1 |
20020123698 | Garibotto et al. | Sep 2002 | A1 |
20020156518 | Tehrani | Oct 2002 | A1 |
20020165535 | Lesh | Nov 2002 | A1 |
20030088187 | Saadat et al. | May 2003 | A1 |
20030204171 | Kucharczyk | Oct 2003 | A1 |
20030216721 | Diederich | Nov 2003 | A1 |
20030229282 | Burdette | Dec 2003 | A1 |
20040002714 | Weiss | Jan 2004 | A1 |
20040073190 | Deem et al. | Apr 2004 | A1 |
20040127975 | Levine | Jul 2004 | A1 |
20040138734 | Chobotov et al. | Jul 2004 | A1 |
20040147837 | Macaulay et al. | Jul 2004 | A1 |
20040167463 | Zawacki | Aug 2004 | A1 |
20050043779 | Wilson | Feb 2005 | A1 |
20050101968 | Dadourian | May 2005 | A1 |
20050113798 | Slater | May 2005 | A1 |
20050113862 | Besselink | May 2005 | A1 |
20050222488 | Chang et al. | Oct 2005 | A1 |
20050234499 | Olson et al. | Oct 2005 | A1 |
20050251160 | Saadat et al. | Nov 2005 | A1 |
20050267010 | Goodson et al. | Dec 2005 | A1 |
20060025752 | Broaddus et al. | Feb 2006 | A1 |
20060025844 | Majercak et al. | Feb 2006 | A1 |
20060030923 | Gunderson | Feb 2006 | A1 |
20060036218 | Goodson | Feb 2006 | A1 |
20060074484 | Huber | Apr 2006 | A1 |
20060155363 | Laduca et al. | Jul 2006 | A1 |
20060200221 | Malewicz | Sep 2006 | A1 |
20060257389 | Binford | Nov 2006 | A1 |
20060259063 | Bates et al. | Nov 2006 | A1 |
20060270900 | Chin et al. | Nov 2006 | A1 |
20070016019 | Salgo | Jan 2007 | A1 |
20070016062 | Park | Jan 2007 | A1 |
20070038061 | Huennekens et al. | Feb 2007 | A1 |
20070038293 | St. Goar et al. | Feb 2007 | A1 |
20070049867 | Shindelman | Mar 2007 | A1 |
20070083215 | Hamer et al. | Apr 2007 | A1 |
20070118151 | Davidson et al. | May 2007 | A1 |
20070129719 | Kendale et al. | Jun 2007 | A1 |
20070219614 | Hartley et al. | Sep 2007 | A1 |
20070288082 | Williams | Dec 2007 | A1 |
20080009829 | Ta | Jan 2008 | A1 |
20080039746 | Hissong et al. | Feb 2008 | A1 |
20080114239 | Randall et al. | May 2008 | A1 |
20080172122 | Mayberry | Jul 2008 | A1 |
20080194993 | Mclaren et al. | Aug 2008 | A1 |
20080208309 | Saeed | Aug 2008 | A1 |
20080281398 | Koss | Nov 2008 | A1 |
20080306467 | Reydel | Dec 2008 | A1 |
20090005679 | Dala-Krishna | Jan 2009 | A1 |
20090018526 | Power et al. | Jan 2009 | A1 |
20090036780 | Abraham | Feb 2009 | A1 |
20090132019 | Duffy et al. | May 2009 | A1 |
20090171293 | Yang et al. | Jul 2009 | A1 |
20090177035 | Chin | Jul 2009 | A1 |
20090240253 | Murray | Sep 2009 | A1 |
20090254116 | Rosenschein et al. | Oct 2009 | A1 |
20090270975 | Giofford, III et al. | Oct 2009 | A1 |
20090319017 | Berez et al. | Dec 2009 | A1 |
20100016943 | Chobotov | Jan 2010 | A1 |
20100024818 | Stenzler et al. | Feb 2010 | A1 |
20100030165 | Takagi et al. | Feb 2010 | A1 |
20100030256 | Dubrul et al. | Feb 2010 | A1 |
20100069852 | Kelley | Mar 2010 | A1 |
20100168583 | Dausch et al. | Jul 2010 | A1 |
20100185161 | Pellegrino et al. | Jul 2010 | A1 |
20100185231 | Lashinski | Jul 2010 | A1 |
20100204708 | Sharma | Aug 2010 | A1 |
20100211095 | Carpenter | Aug 2010 | A1 |
20100268067 | Razzaque et al. | Oct 2010 | A1 |
20100272740 | Vertegel et al. | Oct 2010 | A1 |
20100298922 | Thornton et al. | Nov 2010 | A1 |
20110009943 | Paul et al. | Jan 2011 | A1 |
20110034804 | Hubregtse | Feb 2011 | A1 |
20110034987 | Kennedy | Feb 2011 | A1 |
20110071394 | Fedinec | Mar 2011 | A1 |
20110082533 | Vardi et al. | Apr 2011 | A1 |
20110098681 | Djurivic | Apr 2011 | A1 |
20110196420 | Ebner | Aug 2011 | A1 |
20110224773 | Gifford et al. | Sep 2011 | A1 |
20110230830 | Gifford, III et al. | Sep 2011 | A1 |
20110270375 | Hartley et al. | Nov 2011 | A1 |
20120016343 | Gill | Jan 2012 | A1 |
20120016454 | Jantzen | Jan 2012 | A1 |
20120020942 | Hall et al. | Jan 2012 | A1 |
20120022636 | Chobotov | Jan 2012 | A1 |
20120029478 | Kurosawa | Feb 2012 | A1 |
20120034205 | Alkon | Feb 2012 | A1 |
20120035590 | Whiting et al. | Feb 2012 | A1 |
20120046690 | Blom | Feb 2012 | A1 |
20120169712 | Hill et al. | Jul 2012 | A1 |
20120209375 | Madrid et al. | Aug 2012 | A1 |
20120221094 | Cunningham | Aug 2012 | A1 |
20120289945 | Segermark | Nov 2012 | A1 |
20130053792 | Fischell et al. | Feb 2013 | A1 |
20130131777 | Hartley et al. | May 2013 | A1 |
20130218201 | Obermiller | Aug 2013 | A1 |
20130296773 | Feng et al. | Nov 2013 | A1 |
20130310823 | Gelfand et al. | Nov 2013 | A1 |
20130331819 | Rosenman et al. | Dec 2013 | A1 |
20130331921 | Roubin | Dec 2013 | A1 |
20140031925 | Garrison et al. | Jan 2014 | A1 |
20140114346 | McCaffrey | Apr 2014 | A1 |
20140142427 | Petroff | May 2014 | A1 |
20140214002 | Lieber et al. | Jul 2014 | A1 |
20140214048 | Gulcher | Jul 2014 | A1 |
20140228808 | Webster et al. | Aug 2014 | A1 |
20140276602 | Bonnette | Sep 2014 | A1 |
20140358123 | Kaisha | Dec 2014 | A1 |
20150018942 | Hung et al. | Jan 2015 | A1 |
20150174377 | Syed | Jun 2015 | A1 |
20150190576 | Lee et al. | Jul 2015 | A1 |
20150201900 | Syed | Jul 2015 | A1 |
20150245933 | Syed | Sep 2015 | A1 |
20150352331 | Helm, Jr. | Dec 2015 | A1 |
20150366536 | Courtney et al. | Dec 2015 | A1 |
20150374261 | Grunwald | Dec 2015 | A1 |
20160008058 | Hu et al. | Jan 2016 | A1 |
20160038724 | Madsen et al. | Feb 2016 | A1 |
20160120509 | Syed | May 2016 | A1 |
20160120673 | Siegel et al. | May 2016 | A1 |
20160296355 | Syed | Oct 2016 | A1 |
20160338835 | Van Bladel et al. | Nov 2016 | A1 |
20170119562 | Syed | May 2017 | A1 |
20170119563 | Syed | May 2017 | A1 |
20170135833 | Syed | May 2017 | A1 |
20170181876 | Syed | Jun 2017 | A1 |
20170304095 | Syed | Oct 2017 | A1 |
20170361062 | Syed | Dec 2017 | A1 |
20180042743 | Syed | Feb 2018 | A1 |
20180059124 | Syed | Mar 2018 | A1 |
20180116780 | Laine | May 2018 | A1 |
20180250147 | Syed | Sep 2018 | A1 |
20190091441 | Syed | Mar 2019 | A1 |
20190336114 | Syed | Nov 2019 | A1 |
20200038210 | Syed | Feb 2020 | A1 |
20210196492 | Bagaoisan | Jul 2021 | A1 |
20220152347 | Syed | May 2022 | A1 |
Number | Date | Country |
---|---|---|
108472124 | Aug 2018 | CN |
108472472 | Aug 2018 | CN |
108882975 | Nov 2018 | CN |
109475722 | Mar 2019 | CN |
111629696 | Sep 2020 | CN |
3280355 | Feb 2018 | EP |
3367969 | Sep 2018 | EP |
3368123 | Sep 2018 | EP |
3399944 | Nov 2018 | EP |
3405261 | Nov 2018 | EP |
3471815 | Apr 2019 | EP |
3752104 | Dec 2020 | EP |
201827018555 | Oct 2018 | IN |
201827018768 | Oct 2018 | IN |
201827019509 | Oct 2020 | IN |
WO 1996036269 | Nov 1996 | WO |
199940849 | Aug 1999 | WO |
WO 2004089249 | Oct 2004 | WO |
WO 2010129193 | Nov 2010 | WO |
WO 2011011539 | Jan 2011 | WO |
WO 2011106502 | Sep 2011 | WO |
WO 2011137336 | Nov 2011 | WO |
WO 2012030101 | Aug 2012 | WO |
WO 2014081947 | May 2014 | WO |
WO 2014197839 | Dec 2014 | WO |
WO 2016164215 | Oct 2016 | WO |
WO 2017074492 | May 2017 | WO |
WO 2017074536 | May 2017 | WO |
WO 2017127127 | Jul 2017 | WO |
WO 2017222571 | Dec 2017 | WO |
WO 2017222612 | Dec 2017 | WO |
WO 2018164766 | Sep 2018 | WO |
WO 2019070349 | Apr 2019 | WO |
Entry |
---|
International Search Report and Written Opinion for PCT/US2013/071271 dated Feb. 10, 2014, 7 pages. |
International Search Report and Written Opinion for PCT/US2016/024794 dated Jul. 1, 2016, 10 pages. |
International Search Report and Written Opinion for PCT/US2016/024795 dated Aug. 30, 2016, 14 pages. |
International Search Report and Written Opinion for PCT/US2016/047163 dated Oct. 28, 2016, 9 pages. |
International Search Report and Written Opinion for PCT/US2016/047165 dated Jan. 5, 2017, 13 pages. |
International Search Report and Written Opinion for PCT/US2017/021188 dated May 10, 2017, 11 pages. |
International Search Report and Written Opinion for PCT/US2018/012834 dated Mar. 15, 2018,13 pages. |
International Search Report and Written Opinion for PCT/US2018/047372 dated Jan. 2, 2019, 8 pages. |
International Search Report and Written Opinion for PCT/US2019/012727 dated Mar. 21, 2019, 12 pages. |
International Search Report and Written Opinion for PCT/US2019/12745 dated Apr. 1, 2019, 10 pages. |
International Preliminary Report on Patentability for PCT/US2013/071271 dated May 26, 2015, 6 pages. |
International Preliminary Report on Patentability for PCT/US2016/024795 dated May 1, 2018, 10 pages. |
International Preliminary Report on Patentability for PCT/US2016/047165 dated May 1, 2018, 5 pages. |
International Preliminary Report on Patentability for PCT/US2017/021188 dated Dec. 25, 2018, 9 pages. |
International Preliminary Report on Patentability for PCT/US2016/047163 dated Dec. 25, 2018, 7 pages. |
EP 16777055.1 Extended Search Report dated Feb. 12, 2019, 7 pages. |
EP 18725097.2 Extended Search Report dated Apr. 24, 2019, 9 pages. |
EP 16860437.9 Extended Search Report dated May 17, 2019. |
EP 16906475.5 Extended Search Report dated Jan. 24, 2020. |
EP 17815838.2 Extended Search Report dated Jan. 20, 2020. |
Beckman et al., Venous Thromboembolism: A Public Health Concern, Am J Prev Med., 2010, vol. 38(4), pp. S495-501. |
Blaney et al., Alteplase for the Treatment of Central Venous Catheter Occlusion in Children: Results of a Prospective, Open-Label, Single-Arm Study (The Cathflo Activase Pediatric Study), J Vase Interv Radiol, 2006, vol. 17(11), pp. 1745-1751. |
Godwin, J., The Circulatory and Respiratory Systems, Z0250 Lab III, 2002, retrieved from: https://projects.ncsu.edu/cals/course/zo250/lab-3.html. |
Meunier et al., Individual Lytic Efficacy of Recombinant Tissue Plasminogen Activator in an in-vitro Human Clot Model: Rate of Nonresponse Acad Emerg Med., 2013, vol. 20(5), pp. 449-455. |
Schwartz et al., Intracardiac Echocardiography in Humans using a Small-Sized (6F), Low Frequency (12.5 MHz) Ultrasound Catheter Methods, Imaging Planes and Clinical Experience, Journal of the American College of Cardiology, 1993, vol. 21(1), pp. 189-198. |
Shah, T., Radiopaque Polymer Formulations for Medical Devices, MDDI Medical Diagnostic and Device Industry: Materials, 2001, retrieved from: https://www.mddionline.com/radiopaque-polymer-formulations-medical-devices. |
Tripathi et al., Use of Tissue Plasminogen Activator for Rapoid Dissolution of Fibrin and Blood Clots in the Eye After Surgery for Claucomoa and Cataract in Humans, Drug Development Research, 1992, vol. 27(2), pp. 147-159. |
Stroke Treatments, American Heart Association, Retrieved from: http://www.strokeassociation.org/STROKEORG/AboutStroke/Treatment/Stroke-Treatments_UCM_310892_Article.jsp#V9Hrg2WfV_1 on Sep. 8, 2016. |
Number | Date | Country | |
---|---|---|---|
20210045903 A1 | Feb 2021 | US |
Number | Date | Country | |
---|---|---|---|
62631904 | Feb 2018 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16183066 | Nov 2018 | US |
Child | 17089723 | US |